Parker-Hannifin Q2 EPS Tops Estimates at $7.65, Sales Rise 9%, Guidance Up
Parker-Hannifin reported Q2 adjusted EPS of $7.65 versus $7.17 estimate on $5.17B in net sales, up 9% year-over-year with 6.6% organic growth. It raised FY26 GAAP EPS guidance to $26.26–26.86 and adjusted EPS outlook to $30.40–31.00, spurring Stifel, Wells Fargo and Barclays to increase price targets to $965–$1,050.
1. Robust Q2 Performance and Upgraded Full-Year Guidance
Parker-Hannifin reported second-quarter adjusted earnings per share of $7.65, surpassing analyst consensus by $0.48 and marking a 17% year-over-year increase. Net sales reached $5.174 billion, up 9% from the prior year and $108 million above estimates, driven by 6.6% organic growth. In response, management raised full-year GAAP EPS guidance to a range of $26.26–$26.86 (prior: $25.53–$26.33) and adjusted EPS guidance to $30.40–$31.00 (prior: $29.60–$30.40). Sales guidance was also lifted to $20.942 billion–$21.339 billion from $20.644 billion–$21.239 billion, reflecting confidence in sustained end-market demand and margin expansion under The Win Strategy operating system.
2. Analyst Price Target Increases Reflect Renewed Confidence
Following the quarterly results, Stifel’s Nathan Jones maintained a Hold rating but raised his price target from $941 to $965. Wells Fargo’s Joseph O’Dea retained an Overweight rating and boosted his target from $1,000 to $1,050. Barclays’ Julian Mitchell also stayed Overweight, moving his target from $990 to $1,020. These revisions represent average upside potential of approximately 9% relative to recent share levels and underscore the market’s positive reception of the company’s operational leverage and cash-flow generation capabilities.
3. Industrial Alliance Securities Issues Bullish Outlook
On January 29, 2026, Industrial Alliance Securities set a price target of $1,032, implying potential upside of about 8.8% from current levels. The firm highlighted a 14.5% surge in Aerospace Systems sales and a 6.8% rise in Diversified Industrial segment revenue, which now accounts for 67.1% of total sales. Despite an 11% decline in GAAP net income to $845 million—attributable to last year’s divestiture gains—adjusted net income climbed 15% to $980 million, supporting record free cash flow and reinforcing a healthy balance sheet.